Pharma Logistics Report: Critical to Modern Healthcare Delivery 

HCLS T&L Report Pharma Logistics Header

Harris-Williams Bio-Crop 0009 0181 CheairsPorter

Profile

Harris-Williams Bio-Crop 0020 0095 NickPetrick

HCLS T&L Report Pharma Logistics Web Media

The pharma logistics sector is capturing strong investor attention as it becomes indispensable to modern healthcare delivery.

Pharma Logistics Report: Critical to Modern Healthcare Delivery 

Harris-Williams Bio-Crop 0079 1118 JasonBass

Harris-Williams Bio-Crop 0101 0536 FrankMountcastle

Managing Director

Harris-Williams Bio-Crop 0074 1198 GeoffSmith

Harris-Williams Bio-Crop 0106 0433 TylerBradshaw

Harris-Williams Bio-Crop 0006 SDoering casual

Harris-Williams Bio-Crop 0018 0112 JonMeredith

Harris-Williams Bio-Crop 0065 1456 JeffKidd

bio-crop 0000 0855 RobCrampton

Harris-Williams Bio-Crop 0002 1169 CameronThomas

AIT Worldwide Logistics Partners With Greenbriar Equity Group

6925 AIT Worldwide Logistics NT

Mergers & Acquisitions

Sangro Acquired by Axcel 

6564 Sangro NT

Harris Williams advised Magnate Worldwide, a portfolio company of CIVC Partners, on its sale to Littlejohn & Co. Magnate Worldwide is a diversified supply chain management company offering highly specialized, expedited international and domestic third party logistics (3PL) solutions to shippers around the world.

Magnate Worldwide

United States

5381_magnate_worldwide.png

A leading global provider of reusable and single-use passive thermal packaging solutions for the shipment of temperature-sensitive materials, principally serving the life sciences supply chain.

Cold Chain Technologies

coldchain-web-2.png

Harris Williams advised Inmark Packaging (Inmark), a portfolio company of Quad-C Management, on its investment from funds affiliated with Kelso & Company. Inmark is a leading distributor of life sciences and rigid container packaging.

Inmark Packaging

inmark.png

SSI Strategy Acquired by Clinigen Group

6749 SSI Strategy NT

TPG Growth Completes Continuation Vehicle for AnovoRx

6829 PCA AvonoRx NT

Mercalis Merges With PharmaCord

6381 Mercalis NT

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Security and Fraud Awareness

Site Map

Privacy Policy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Select Activity

Third-Party Logistics: Specialization in Demand

Innovative Cold Chain Solutions That Protect Patients

Outsourced Pharma Services: SSI Strategy Combines Science and Consulting Expertise

The Convergence of Pharmacy and Pharma Services: Hub Services Show Opportunity

Select Activity

Related Insights

Third-Party Logistics: Specialization in Demand

Innovative Cold Chain Solutions That Protect Patients

Outsourced Pharma Services: SSI Strategy Combines Science and Consulting Expertise

The Convergence of Pharmacy and Pharma Services: Hub Services Show Opportunity